Table 1.
Characteristic | ALD (n = 86) | NAFLD (n = 53) | t/Z/X2 | p value |
---|---|---|---|---|
Demographic | ||||
Sex, male:female | 85:1 | 37:16 | 25.74 | < 0.001 |
Age, yr | 49.47 ± 10.31 | 39.58 ± 14.37 | –4.710 | < 0.001 |
Clinical | ||||
BMI, kg/m2 | 23.60 ± 3.59 | 26.17 (3.90) | –4.352 | < 0.001 |
WC, cm | 89.62 ± 9.56 | 93.68 ± 10.68 | 1.978 | 0.026 |
SBP, mmHg | 121.36 ± 10.32 | 123.76 ± 11.67 | 1.977 | 0.208 |
DBP, mmHg | 79.69 ± 8.64 | 82.48 ± 9.06 | 1.304 | 0.072 |
Biochemical | ||||
LDL-C, mmol/L | 2.87 ± 1.28 | 2.92 (0.86) | –0.410 | 0.682 |
TG, mmol/L | 1.92 (1.74) | 1.78 (1.21) | –1.003 | 0.316 |
TC, mmol/L | 5.14 (2.80) | 4.80 ± 1.18 | 0.961 | 0.336 |
FBG, mmol/L | 6.02 (1.75) | 5.63 (0.96) | 0.676 | 0.499 |
AST/ALT | 1.66 (1.24) | 0.52 (0.23) | –6.487 | < 0.001 |
MCV, fl | 98.84 ± 8.64 | 89.60 (6.40) | –6.249 | < 0.001 |
GGT, IU/L | 245.0 (602.50) | 58.0 (41.60) | –6.225 | < 0.001 |
Ultrasonography | ||||
Accuracy, % | 78 (90.68) | 50 (94.34) | 0.597 | 0.440 |
FibroScan parameter | ||||
CAP, dB/m | 242.87 ± 28.15 | 254.23 ± 50.46 | 1.98 | 0.091 |
Values are presented as mean ± SD or median (4th percentile interval).
ALD, alcoholic liver disease; NAFLD, nonalcoholic fatty liver disease; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, low density lipoprotein cholesterol; TG, triglyceride; TC, total cholesterol; FBG, fasting blood glucose; AST/ALT, alanine aminotransferase/aspartate aminotransferase; MCV, mean corpuscular volume; GGT, γ-glutamyl transpeptidase; CAP, controlled attenuation parameter.